Extracellular Purine Metabolism Is the Switchboard of Immunosuppressive Macrophages and a Novel Target to Treat Diseases With Macrophage Imbalances.
Ohradanova-Repic A, Machacek C, Charvet C, Lager F, Le Roux D, Platzer R, Leksa V, Mitulovic G, Burkard TR, Zlabinger GJ, Fischer MB, Feuillet V, Renault G, Blüml S, Benko M, Suchanek M, Huppa JB, Matsuyama T, Cavaco-Paulo A, Bismuth G, Stockinger H.
Ohradanova-Repic A, et al. Among authors: lager f.
Front Immunol. 2018 Apr 27;9:852. doi: 10.3389/fimmu.2018.00852. eCollection 2018.
Front Immunol. 2018.
PMID: 29780382
Free PMC article.